Market overview
The global infusion pump market is worth USD 6.9 bn in 2026 and is forecast to reach USD 11.5 bn by 2036, growing at a 5.2% CAGR. United States is the largest country market and Large volume is the largest by type segment.
| Scope | Infusion pumps: large-volume, syringe, ambulatory, patient-controlled and enteral pumps with their drug libraries and software. |
|---|---|
| Industry | Healthcare |
| Value 2025 | USD 6.6 bn |
| Value 2026 | USD 6.9 bn |
| Value 2036 | USD 11.5 bn |
| CAGR 2026-2036 | 5.2% |
| Volume 2026 | 1,670 thousand units |
| Volume 2036 | 2,560 thousand units |
| Average price 2026 | USD 4,158 per unit |
| Report price | Starts from USD 1,999 |
| Published | November 2026 |
Request a free sample of this report
Infusion Pump market size and forecast, 2026-2036
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| Year | Market value |
|---|---|
| 2026 | USD 6.9 bn |
| 2027 | USD 7.3 bn |
| 2028 | USD 7.7 bn |
| 2029 | USD 8.1 bn |
| 2030 | USD 8.5 bn |
| 2031 | USD 8.9 bn |
| 2032 | USD 9.4 bn |
| 2033 | USD 9.9 bn |
| 2034 | USD 10.4 bn |
| 2035 | USD 11.0 bn |
| 2036 | USD 11.5 bn |
Infusion Pump market segmentation
By type
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Large volume | 40.0% | 38.2% | USD 2.8 bn | 4.7% |
| Syringe | 22.0% | 22.1% | USD 1.5 bn | 5.2% |
| Ambulatory | 14.0% | 14.7% | USD 972 mn | 5.7% |
| Patient-controlled analgesia | 10.0% | 9.6% | USD 694 mn | 4.7% |
| Enteral and specialty | 14.0% | 15.4% | USD 972 mn | 6.2% |
By end user
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Hospitals | 66.0% | 59.8% | USD 4.6 bn | 4.2% |
| Ambulatory and home care | 24.0% | 30.2% | USD 1.7 bn | 7.7% |
| Clinics and long-term care | 10.0% | 10.0% | USD 694 mn | 5.2% |
By technology
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Smart and interoperable | 52.0% | 64.7% | USD 3.6 bn | 7.5% |
| Standard connected | 12.0% | 11.3% | USD 833 mn | 4.5% |
| Conventional | 36.0% | 24.1% | USD 2.5 bn | 1.1% |
By application
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Fluid and drug delivery | 32.0% | 30.0% | USD 2.2 bn | 4.5% |
| Chemotherapy | 22.0% | 22.0% | USD 1.5 bn | 5.2% |
| Pain management | 18.0% | 17.0% | USD 1.2 bn | 4.6% |
| Diabetes | 14.0% | 17.0% | USD 972 mn | 7.3% |
| Nutrition | 14.0% | 14.0% | USD 972 mn | 5.2% |
By channel configuration
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Single-channel | 56.0% | 52.0% | USD 3.9 bn | 4.4% |
| Dual-channel | 24.0% | 24.0% | USD 1.7 bn | 5.2% |
| Multi-channel | 20.0% | 24.0% | USD 1.4 bn | 7.1% |
Top 25 countries for infusion pump by revenue
Countries are ranked by revenue earned from sales in the country, not by where the product is made. The ten largest hold 77.5% of 2026 revenue and the 25 countries below together hold 93.7%.
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| # | Country | Value 2026 | Share 2026 | Value 2036 | CAGR 2026-36 |
|---|---|---|---|---|---|
| 1 | United States | USD 2.6 bn | 38.0% | USD 3.9 bn | 4.1% |
| 2 | China | USD 555 mn | 8.0% | USD 1.3 bn | 9.1% |
| 3 | Germany | USD 417 mn | 6.0% | USD 657 mn | 4.7% |
| 4 | Japan | USD 417 mn | 6.0% | USD 622 mn | 4.1% |
| 5 | France | USD 278 mn | 4.0% | USD 415 mn | 4.1% |
| 6 | United Kingdom | USD 278 mn | 4.0% | USD 438 mn | 4.7% |
| 7 | Italy | USD 208 mn | 3.0% | USD 311 mn | 4.1% |
| 8 | Canada | USD 208 mn | 3.0% | USD 323 mn | 4.5% |
| 9 | India | USD 208 mn | 3.0% | USD 542 mn | 10.0% |
| 10 | Brazil | USD 174 mn | 2.5% | USD 311 mn | 6.0% |
| 11 | Spain | USD 122 mn | 1.8% | USD 188 mn | 4.5% |
| 12 | South Korea | USD 106 mn | 1.5% | USD 164 mn | 4.4% |
| 13 | Australia | USD 106 mn | 1.5% | USD 164 mn | 4.4% |
| 14 | Mexico | USD 91 mn | 1.3% | USD 175 mn | 6.8% |
| 15 | Russia | USD 91 mn | 1.3% | USD 141 mn | 4.5% |
| 16 | Turkey | USD 91 mn | 1.3% | USD 175 mn | 6.8% |
| 17 | Netherlands | USD 76 mn | 1.1% | USD 118 mn | 4.5% |
| 18 | Saudi Arabia | USD 61 mn | 0.9% | USD 118 mn | 6.8% |
| 19 | Poland | USD 61 mn | 0.9% | USD 93 mn | 4.3% |
| 20 | Indonesia | USD 61 mn | 0.9% | USD 141 mn | 8.7% |
| 21 | Switzerland | USD 61 mn | 0.9% | USD 93 mn | 4.3% |
| 22 | Taiwan | USD 61 mn | 0.9% | USD 93 mn | 4.3% |
| 23 | Egypt | USD 46 mn | 0.7% | USD 88 mn | 6.7% |
| 24 | Thailand | USD 46 mn | 0.7% | USD 88 mn | 6.7% |
| 25 | Argentina | USD 46 mn | 0.7% | USD 70 mn | 4.4% |
| Rest of world | USD 437 mn | 6.3% | USD 732 mn | 5.3% |
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
Competitive landscape
Group 1: Global leaders
- Becton Dickinson
- Baxter
- ICU Medical
- B. Braun
- Fresenius Kabi
- Terumo
Group 2: Regional and specialist players
- Mindray
- Nipro
- Eitan Medical
- Micrel Medical Devices
- Sino Medical-Device Technology
- Arcomed
- Cane
Group 3: Emerging and niche players
- Zyno Medical
- Medcaptain
- Woo Young Medical
- Sooil Development
- InfuSystem
Research methodology
Every figure on this page comes from the research framework that we apply to all of the markets we cover. The 2025 base for the infusion pump market is built from the volume sold and the price that buyers pay, and is cross-checked against the size of the wider industry the market belongs to. Where a market can be sized in more than one way, the routes are compared before a figure is set.
The forecast runs year by year from the 2025 base to 2036. Growth in each year reflects demand from the industries that buy the product, adoption of new technology, pricing, regulation and replacement cycles. Volume and price are modelled together, so revenue in each year equals volume multiplied by average price. The 2026 to 2036 compound annual growth rate of 5.2% is calculated from the resulting values.
The market is divided by type, by end user, by technology, by application, by channel configuration. The 25 largest countries are ranked by revenue earned from sales to buyers in each country, not by where the product is made. Segment values and country values add up to the market total in every year, and every report is checked for consistency before it is published.
Companies are placed in three groups: global leaders, regional and specialist players, and emerging and niche players. The groups describe how companies compete in the market. They are not a ranking and they are not market shares.
Our analysts also carry out primary research. Customized reports add interviews with key opinion leaders, such as senior executives, technical specialists and buyers, to test the assumptions behind the numbers for the question being asked.
Frequently asked questions
How big is the infusion pump market?
The global infusion pump market is estimated at USD 6.6 bn in 2025 and USD 6.9 bn in 2026.
How fast will the infusion pump market grow?
It is forecast to reach USD 11.5 bn by 2036, a compound annual growth rate of 5.2% from 2026, an increase of USD 4.6 bn.
Which country is the largest market for infusion pump?
United States is the largest market by revenue at USD 2.6 bn in 2026, 38.0% of the global total. The three largest countries together hold 52.0%.
Which country is growing fastest?
Among the ten largest markets, India is growing fastest at 10.0% a year from 2026 to 2036.
Which infusion pump segment is largest?
In the by type split, Large volume is the largest segment with 40.0% of 2026 revenue.
Who are the leading infusion pump companies?
Global leaders include Becton Dickinson, Baxter, ICU Medical, B. Braun.
Need the full report?
Request a sample to see the structure, tables and country detail.
Request a free sampleRelated markets in Healthcare
- Laboratory AutomationUSD 7.0 bn · 8.0% CAGR
- Cleanroom ConsumableUSD 6.7 bn · 7.5% CAGR
- Pen InjectorUSD 6.7 bn · 10.0% CAGR
- RadiotherapyUSD 7.2 bn · 6.8% CAGR
- Mass SpectrometryUSD 6.6 bn · 7.0% CAGR
- Cell Culture MediaUSD 7.4 bn · 8.0% CAGR
- Fiber SupplementsUSD 6.4 bn · 6.5% CAGR
- UltrafiltrationUSD 6.4 bn · 9.5% CAGR